US Patent Issued to Iterion Therapeutics on Jan. 28 for "Lyophilized formulations of tegavivint" (California, Texas Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,166, issued on Jan. 28, was assigned to Iterion Therapeutics Inc. (Houston).

"Lyophilized formulations of tegavivint" was invented by Gowri Sukumar (Spring, Texas) and Drazen Ostovic (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations."

The patent was filed on Oct. 24, 2023, under Application No. 18/383,389.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.h...